The TGTX chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the TGTX chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The TGTX stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
View TGTX Detailed Price Forecast - CNN Money | View TGTX Detailed Summary - Google Finance | ||
View TGTX Detailed Summary - Yahoo! Finance | View TGTX Stock Research & Analysis - Zacks.com |
View TGTX Trends & Analysis - Trade-Ideas | View TGTX Major Holders - Barrons | ||
View TGTX Call Transcripts - NASDAQ | View TGTX Breaking News & Analysis - Seeking Alpha | ||
View TGTX Annual Report - CompanySpotlight.com | View TGTX OTC Short Report - OTCShortReport.com | ||
View TGTX Fundamentals - TradeKing | View TGTX SEC Filings - Bar Chart | ||
View Historical Prices for TGTX - The WSJ | View Performance/Total Return for TGTX - Morningstar | ||
View the Analyst Estimates for TGTX - MarketWatch | View the Earnings History for TGTX - CNBC | ||
View the TGTX Earnings - StockMarketWatch | View TGTX Buy or Sell Recommendations - MacroAxis | ||
View the TGTX Bullish Patterns - American Bulls | View TGTX Short Pain Metrics - ShortPainBot.com |
View TGTX Stock Mentions - StockTwits | View TGTX Stock Mentions - PennyStockTweets | ||
View TGTX Stock Mentions - Twitter | View TGTX Investment Forum News - Investor Hub | ||
View TGTX Stock Mentions - Yahoo! Message Board | View TGTX Stock Mentions - Seeking Alpha |
View Insider Transactions for TGTX - SECform4.com | View Insider Transactions for TGTX - Insider Cow | ||
View TGTX Major Holdings Summary - CNBC | View Insider Disclosure for TGTX - OTC Markets | ||
View Insider Transactions for TGTX - Yahoo! Finance | View Institutional Holdings for TGTX - NASDAQ |
View TGTX Stock Insight & Charts - FinViz.com | View TGTX Investment Charts - StockCharts.com | ||
View TGTX Stock Overview & Charts - BarChart | View TGTX User Generated Charts - Trading View |
Is TG Therapeutics, Inc.'s (NASDAQ:TGTX) Recent Price Movement Underpinned By Its Weak Fundamentals?
Posted on Tuesday March 19, 2024
It is hard to get excited after looking at TG Therapeutics' (NASDAQ:TGTX) recent performance, when its stock has...
13 Best Biotech Stocks To Buy Under $20
Posted on Wednesday March 13, 2024
In this article, we’re going to take a look at 13 best biotech stocks to buy under $20. To see more stocks that made the list, you can skip ahead and jump straight to the top 5 best biotech stocks to buy under $20. When it comes to investing, few industries are as exciting to […]
TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the American Academy of Neurology 2024 Annual Meeting
Posted on Friday March 08, 2024
NEW YORK, March 08, 2024 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the schedule of data presentations highlighting data from the ULTIMATE I & II Phase 3 trials evaluating BRIUMVI® (ublituximab-xiiy) in patients with relapsing forms of multiple sclerosis (RMS), at the upcoming American Academy of Neurology 2024 annual meeting, being held April 13 - 18, 2024, in Dever, Colorado. Abstracts are now available online and can be accessed on the AAN meeting website at htt
TG Therapeutics Announces Presentation of Data for BRIUMVI® in Multiple Sclerosis at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Forum
Posted on Friday March 01, 2024
NEW YORK, March 01, 2024 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the presentation of data from the ULTIMATE I & II Phase 3 trials and the ENHANCE Phase 3b trial evaluating BRIUMVI® (ublituximab-xiiy) in patients with relapsing forms of multiple sclerosis (RMS), at the Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) annual forum, being held in West Palm Beach, Florida. Links to each presentation are included below. Michael S. Weiss,